Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

House Dust Mite Injection Immunotherapy: a Double-blind, Placebo Controlled Study in Elderly Patients With Allergic Rhinitis.

NCT03209245 is registered in ClinicalTrials.gov with Medical University of Silesia as lead sponsor.

NCT NCT03209245
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03209245 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
House Dust Mite Injection Immunotherapy: a Double-blind, Placebo Controlled Study in Elderly Patients With Allergic Rhinitis.
Lead sponsor
Medical University of Silesia
Phase
Phase 3
Overall status
Completed
Start date
April 10, 2014
Completion date
April 15, 2017
Enrollment
58 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

allergen immunotherapy in elderly patients